Keywords: merck, co, reaffirms, cautious, eps, reaffirmed, its
Merck & Co's reaffirms cautious 2006 EPS
Article | 18 December 2006
Merck & Co reaffirmed its full-year 2006 profit forecast, predicting earnings per share of $2.48 to $2.52. The US drug major also stated modest ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
